Delphi Screener HK

Most countries goverment recommened that a wowen commences cervical screening from age 25, after becoming sexually active. These unscreened and under-screened women are at high risk of getting Cervical Cancers. Many women are busy and cannot make time for screening. Some are shy or fearful of havig a Pap test. An effective way to help the unscreened and under-screened women is to appeal to them by providing convenience, privacy and minimal discomfort, under clinical supervision. Our Delphi Screener has met success in reaching out to the unscreened and under-screened women. The results of the large Clinical Trials are as follows:
- Large-scale hr-HPV testing in population-based cervical screening is feasible, accepted by women and gerenal practitioners and yields highly reproducible results.
- Self-obtained samples by this novel device are highly representative of the hr-HPV status of the cervix.
- self-sampling was as sensitive as physician-obtained sampling to detect hr-HPV or HPV DNA.
- Offering self-sampling to women who did not attnd regular screening is a feasible and effective method of increasing converage.
- HPV DNA testing in cervical screening leads to earlier detection of clinically relevant CIN grade 2 or worse. If you want to know more our product information, pls visit in www.delphiscreener.asia